Interestingly, a number of clinical and translational studies have shown that serum levels of different bone morphogenetic proteins (BMPs) are modulated in patients with CLD, particularly BMP2 [13], BMP7 [14–16], BMP9 and BMP10 [17]. This evidence concerns the gene CLN5 and congenital secretory chloride diarrhea 1.